Remarkable objective response and favorable survival for BRAF-V600E childhood low-grade gliomas to BRAF inhibitors compared conventional chemotherapy Meeting Abstract


Authors: Zapotocky, M.; Ryall, S.; Fukuoka, K.; Guerreiro Stucklin, A.; Bennett, J.; Sumerauer, D.; Pavelka, Z.; Cruz, O.; Solano, P.; Garre, M. L.; Hauser, P.; Frappaz, D.; Hansford, J.; Amayiri, N.; Morse, H.; Sabel, M.; Bechensteen, A. G.; Su, J.; Karajannis, M.; Finlay, J.; Eisenstat, D.; Canete, A.; Toledano, H.; Dahiya, S.; Leary, S.; Nicolaides, T.; Finch, E.; Mueller, S.; Levy, J. M.; Ellison, D.; Lassaletta, A.; Larouche, V.; Ramaswamy, V.; Dirks, P.; McKeown, T.; Bartels, U.; Bouffet, E.; Hawkins, C.; Tabori, U.; on behalf of PLGG Taskforce
Abstract Title: Remarkable objective response and favorable survival for BRAF-V600E childhood low-grade gliomas to BRAF inhibitors compared conventional chemotherapy
Meeting Title: 18th International Symposium on Pediatric Neuro-Oncology (ISPNO 2018)
Journal Title: Neuro-Oncology
Volume: 20
Issue: Suppl. 2
Meeting Dates: 2018 Jun 29-Jul 3
Meeting Location: Denver, CO
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2018-06-22
Start Page: i117
Language: English
ACCESSION: WOS:000438339000401
PROVIDER: wos
DOI: 10.1093/neuonc/noy059
PMCID: PMC6012612
Notes: Meeting Abstract: LGG-59 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors